Sickle cell anemia : An example of the polygenic modulation of monogenic diseases;Modulation polygénique des maladies monogéniques : L'exemple de la drépanocytose

Medecine/Sciences

Volumn 12, Issue 3, 1996, Pages 341-349

  Labie, Dominique ^a,b   Elion, Jacques ^a,b  

^a CHU Cochin ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; HEMOGLOBIN S;

ALPHA THALASSEMIA; BLOOD CLOTTING; BLOOD RHEOLOGY; CELL ADHESION; GENE LOCATION; GENE MUTATION; HUMAN; PATHOPHYSIOLOGY; POLYMERIZATION; RETICULOCYTE; REVIEW; SICKLE CELL ANEMIA; TRANSACTIVATION; VASCULAR ENDOTHELIUM;

EID: 0029878430     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/737     Document Type: Article

References (51)

1. Noguchi CT, Schechter AN, Rodgers GP. Sickle cell disease pathophysiology. In: Higgs D, Weatherall DJ, eds. The haemoglobinopathies. Bailliere's Clinical Haematology, vol. 6. London: Baillière Tindall, 1993: 57-91.
2. Rosa J. Un modèle en recherche clinique: la drépanocytose. médecine/sciences 1986; 2: 558-67.
3. Serjeant GR. The clinical features of sickle cell disease. In: Higgs D, Weatherall DJ, eds. The Haemoglobinopathies. Bailliere's Clinical Haematology, vol. 6. London: Bailliere Tindall, 1993: 93-115.
4. Bodmer J, Cavalli-Sforza LL. Genetics, evolution and man. San Francisco: Freeman, 1976.
5. Lehmann H, Huntsman RG. Man's haemoglobins. Amsterdam, Oxford: North Holland Publishing Company, 1966.
6. Perrine RP, Pembrev ME, John P, Perrine S, Shoup F. Natural history of sickle cell anemia in Saudi Arabs. Ann Intern Med 1978; 88: 1-6.
7. Brittenham G, Lozoff B, Harris JW, Sharma VS, Narasimhan S. Sickle cell anemia and trait in a population of Southern India. Am J Hematol 1977; 2: 25-32.
8. Kan YM, Dozy AM. Polymorphism of DNA sequence adjacent to human β-globin structural gene: relationship to sickle mutation. Proc Natl Acad Sci USA. 1978; 75: 5631-5.
9. Pagnier J, Mears JG, Dunda-Belkhodja O, Schaefer-Rego K, Beldjord C, Nagel RL, Labie D. Evidence for the multicentric origin of the sickle hemoglobin gene in Africa. Proc Natl Acad Sci USA 1984; 81: 1771-3.
10. S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation. Am J Hum Genet 1986; 9: 239-44.
11. Lapouméroulie C, Dunda O, Ducrocq R, Trabuchet G, Mony-Lobé M, Bodo JM, Carnevale P, Labie D, Elion J, Krishnamoorthy R. A novel sickle cell mutation of yet another origin in Africa: the Cameroon type Hum Genet 1992; 89: 333-7.
12. Berg PE, Mittelman M, Elion J, Labie D, Schechter AN. Increased protein binding to a -530 mutation of the human β-globin gene associated with decreased β-globin synthesis. Am J Hematol 1991; 36: 42-7.
13. S mutation. Blood 1992; 79: 787-92.
14. Talbot D, Philipsen S, Fraser P, Grosveld F. Detailed analysis of the site 3 region of the human β-globin dominant control region. EMBO J 1990; 9: 2169-78.
15. Liu D, Chang JC, Moi P, Liu W, Kan YW, Curtin PT. Dissection of the enhancer activity of β-globin 5′ DNase I-hypersensitive site 2 in transgenic mice. Proc Natl Acad Sci USA 1992; 89. 3899-903.
16. Périchon B, Ragusa A, Lapouméroulie C, Romand A, Moi P, Ikuta T, Labie D, Elion J, Krishnamoorthy R. Inter-ethnic polymorphism of the β-globin gene locus control region (LCR) in sickle-cell anemia patients. Hum Genet 1993; 91: 464-8.
17. Powers PA, Smithies O. Short gene conversions in the human fetal globin gene recoil; a by-product of chromosome pairing during meiosis. Genetics 1986; 112: 343-58.
18. Aγ IVS2 (TG) repeat region and its relevance to HbF response in stress anemia Blood 1995; 80 (suppl 1): 80a.
19. Donovan-Peluso M, Acuto S, O'Neill D, Kavsen J, Hom A, Maggio A, Bank A. The regulation of γ-globin gene expression Ann NY Acad Sci 1990; 612: 160-5.
20. Sampietro M, Thein SL, Contreras M, Pazmany L. Variation of Hb F and F-cell number with the G-γ XmnI (C-T) polymorphism in normal individuals. Blood 1992; 79 832-3
21. S chromosomes beating the Bantu haplotype. Hum Genet 1990; 47: 161-3.
22. Aγ globin gene coincides with decreased gene expression. Hum Genet 1992; 89: 625-8.
23. Pissard S, Beuzard Y. A potential regulatory region for the expression of fetal hemoglobin in sickle cell disease. Blood 1994; 84: 331-8.
24. Aγ enhancer region are linked to β-gene cluster haplotypes and are unrelated to fetal hemoglobin expression. Am J Hum Genet 1989; 45: 106-11.
25. Embury SH, Steinberg MH. Genetic modulators of disease. In Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle cell disease. Basic principles and clinical practice. New York: Raven Press, 1994: 279-98.
26. Kulozik A, Kar BC, Serjeant GR, Serjeant BE, Weatherall DJ. The molecular basis of α thalassemia in India. Its interaction with the sickle cell gene. Blood 1988; 71: 467-72.
27. S mutation and the unicentric origin of the tribal populations of India. Hum Biol 1989; 61: 479-91.
28. Mukherjee MB, Lu CY, Ducrocq R, Gangakhedakar RN, Colah RB, Kadam MD, Mohanty D, Nagel RL, Krishnamoorthy R. Sickle cell anemia linked to Arab-India haplotype in two populations with different levels of alpha thalassemia. 20th Annual meeting of the national sickle cell disease program. Boston march 18-21, 1995; p. 208.
29. Christakis J, Vavatsi N, Hassapopoulou H, Papadopoulou M, Mandraveli K, Loukopoulos D, Morris JS, Serjeant BE, Serjeant GR. Comparison of homozygous sickle cell disease in Northern Greece and Jamaica. Lancet 1990; 335: 637-40.
30. Miyoshi K, Kaneto Y, Kawai H, Ohchi H, Niki S, Hasegawa K, Shirakami A, Yamano T. X-linked dominant control of F-cells in normal adult life: characterization of the Swiss type as hereditary persistence of fetal hemoglobin regulated dominantly by gene(s) on X chromosome. Blood 1988; 72: 1854-60.
31. Dover GJ, Smith KD, Chang YC, Purvis S, Mays A, Meyers DA, Sheils C, Serjeant G. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood 1992; 80: 816-24.
32. Chang YC, Smith KD, Moore RD, Serjeant GR, Dover GJ. An analysis of fetal hemoglobin variation in sickle cell disease: the relative contributions of the X-linked factor, β-globin haplotypes, α-globin gene number, gender, and age. Blood 1995; 85: 1111-7.
33. Thein SL, Sampietro M, Rohde K, Rochette J, Weatherall DJ, Lathrop GM, Demenais F. Detection of a major gene for heterocellular hereditary persistence of fetal hemoglobin after accounting for genetic modifiers. Am J Hum Genet 1994; 54: 214-28.
34. Craig JE, Rochette J, Fisher C, Weatherall DJ, Marc S, Lathrop GM, Demenais F, Thein SL. Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach Nature Genet 1996; 12: 58-64.
35. Hebbel RP. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood 1991; 77: 214-37.
36. Ciu D, Lubin B, Eoelofsen B, Van Deenen L. Sickled erythrocytes accelerate clotting in vitro: an effect of abnormal membrane lipid asymmetry. Blood 1981; 58: 398-401.
37. Mohandas N, Evans E. Rheological and adherence properties of sickle cells. Potential contribution to hematological manifestations of the disease. Ann NY Acad Sci 1989; 565: 327-37.
38. Gee BE, Platt OS. Sickle reticulocytes adhere to VCAM-1. Blood 1995; 85: 268-74.
39. Francis RB Jr, Johnson CS. Vascular occlusion in sickle cell disease: current concepts and unanswered questions. Blood 1991; 77: 1405-14.
40. Smolinski PA, Offermann MK, Eckman JR, Wick TM. Double-stranded RNA induces sickle erythrocyte adherence to endothelium: a potential role for viral infection in vaso-occlusive pain episodes in sickle cell anemia. Blood 1995; 85: 2945-50.
41. Agre P. The aquaporin water channels. 20th Annual meeting of the national sickle cell disease program. Boston, march 18-21, 1995.
42. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
43. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
44. Haldane JBS. The relative importance of principal and modifying genes in determining some human diseases. J Genet 1941; 41: 149-57.
45. Férec C, Mercier B, Audrézet M. Les mutations de la mucoviscidose: du génotype au phénotype. médecine/sciences 1994; 10: 631-9.
46. Dean M, Santis G. Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations. Hum Genet 1994; 93: 364-8.
47. Kiesewetter S, Macek M Jr, Davis C, Curristin SM, Chu CS, Graham C, Shrimpton AE, Cashman SM, Tsui L, Mickle J, Amos J, Highsmith WE, Shuber A, Witt DR, Crystal RG, Cutting GR. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nature Genet 1993; 5: 274-7.
48. Chu CS, Trapnell BC, Curristin S, Moss J, Dalemans W, Jallat S, Mercenier A, Pavirani A, Lecocq JP, Cutting GR, Guggino WB, Crystal RG. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nature Genet 1993; 3: 151-6.
49. Wolf U. The genetic contribution to the phenotype. Hum Genet 1995; 95: 127-48.
50. Valentijn LJ, Baas F, Wolterman RA, Hoogendijk JE, van den Bosh NHA, Zorn I, Gabreëls-Festen AAWM, de Visser M, Bolhuis P. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nature Genet 1992; 2: 288-91.
51. Rutland P, Pulleyn LJ, Reardon W, Barattser M, Hayward R, Jones B, Malcolm S, Winter RM, Oldridge M, Slanev SF, Poole MD, Wilkie AOM. Identical mutations in the FGFR2 gene causes both Pfeiffer and Crouzon syndrome phenotypes. Nature Genet 1995; 9: 173-6.